abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Net Receivables
$1.27M
Quarterly · Period ending: · USD
HQL Net Receivables
Latest reported$1.27Mperiod ending
Latest reported$1.27Mperiod ending
HQL Quarterly Net Receivables ($0.00 → $1.27M)
Quarterly net receivables
High-resolution chart · PNG
HQL net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 1,268,308 | |
| 1,138,099 | |
| 6,387,762 | |
| 231,106 | |
| 112,964 | |
| 5,044,638 | |
| 12,818 | |
| 623,472 | |
| 3,101,413 | |
| 150,341 | |
| 5,409 | |
| 73,897 | |
| 4,837,232 | |
| 4,362,019 | |
| 6,049,526 | |
| 11,192,123 | |
| 86,886 | |
| 712,113 | |
| 5,638,241 | |
| 10,229,335 | |
| 241,307 | |
| 1,522,034 | |
| 2,954,755 | |
| 595,097 | |
| 1,744,935 | |
| 4,367,856 | |
| 2,762,912 | |
| 6,240,370 | |
| 800,000 | |
| 650,000 | |
| 500,000 | |
| 1,750,000 | |
| 3,000,000 | |
| 2,400,000 | |
| 1,800,000 | |
| 1,000,000 | |
| 200,000 | |
| 800,000 | |
| 1,400,000 | |
| 1,950,000 | |
| 2,500,000 | |
| 1,500,000 | |
| 500,000 | |
| 300,000 | |
| 100,000 | |
| 550,000 | |
| 1,000,000 | |
| 1,250,000 | |
| 1,500,000 | |
| 100,000 | |
| 0 | |
| 0 | |
| 0 |